Aphaia Pharma
Phase 2Harnessing precision-targeted drug formulations for the treatment and prevention of metabolic disorders such as obesity and related diseases
Founded
2016
Focus
Drug Delivery
About
Harnessing precision-targeted drug formulations for the treatment and prevention of metabolic disorders such as obesity and related diseases
Funding History
1Total raised: $2.5M
Seed$2.5MHigh-Tech GründerfondsJun 15, 2021
Company Info
TypePrivate
Founded2016
LocationZug, Switzerland
StagePhase 2
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile